Table 2.
Comparison between BOH group and control group in medical complications and fetal outcome
| Control group (n=300) | BOH group (n=79) | Fisher exact test p value | Relative risk | |
|---|---|---|---|---|
| Anti phospholipids antibody (APLA) ♯♯ | 12 (4%) | 8 (10.13 %) | 0.044** | 2.532 |
| Hypothyroid | 15 (5%) | 6 (7.59 %) | 0.406 | 1.519 |
| Tuberculosis under treatment | 3 (1%) | 1 (1.26%) | 1 | 1.266 |
| Gestational diabetes mellitus (GDM) | 7 (2.33%) | 2 (2.53%) | 1 | 1.085 |
| Hypertension $ | 16 (5.33%) | 16 (20.25%) | 0.000** | 3.797 |
| Premature rupture of membranes (PROM) | 31 (10.33%) | 12 (15.19%) | 0.234 | 1.470 |
| Ante partum haemorrhage (APH) | 14 (4.67%) | 2 (2.53%) | 0.540 | 0.542 |
| Malpresentation | 7 (2.33%) | 6 (7.59%) | 0.034** | 3.255 |
| Cervical incompetence *** | 0 | 4 (5.06%) | 0.002** | infinite |
| Fetal distress ♯ | 26 (8.67%) | 9 (11.39%) | 0.512 | 1.315 |
| LSCS | 68 (22.67%) | 49 (62.02%) | 0.000** | 2.736 |
| Vacuum/forceps delivery | 21 (7%) | 4 (5.06%) | 0.799 | 0.723 |
| Meconium stained liquor (MSL) | 45 (15%) | 15 (18.99 %) | 0.389 | 1.266 |
| Preterm delivery | 19 (6.33%) | 14 (17.72%) | 0.003** | 2.798 |
| Still birth | 1 (0.33%) | 01 | 0.000 |
**
Significant,
***
funneling of cervix in USG between 20-30 weeks of pregnancy, history of cervical incompetence in previous pregnancy,
♯
as manifested by fetal bradycardia, variable or late decelerations,
♯♯
high levels of APLA and/or anticardiolipin antibody and/or lupus anticoagulant and/or prolonged activated partial thromboplastin time (aPTT),
$
includes chonic hypertension and pregnancy induced hypertension (PIH).